Diabetes and hypertriglyceridemia modify the mode of acetaminophen-induced hepatotoxicity and nephrotoxicity in rats and mice

Journal of Toxicological Sciences

Volumn 34, Issue 1, 2009, Pages 1-11

  Doi, Kunio ^a,b   Ishida, Katsuhiko ^c  

^a NIPPON INSTITUTE FOR BIOLOGICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c BIOGEN   (United States)

Author keywords

Acetaminophen; Diabetes; Hepatorenal toxicity; Hypertriglyceridemia; Mouse; Rat

Indexed keywords

PARACETAMOL;

DIABETES MELLITUS; DISEASE MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; HYPERTRIGLYCERIDEMIA; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; REVIEW;

ANIMALIA; MUS; RATTUS;

EID: 59949093547     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.1     Document Type: Review

References (137)

1. Abdel-Zaher, A.O., Abdel-Rahman, M.M., Hafez, M.M., and Omran, F.M. (2007): Role of nitric oxide and reduced glutathione in the protective effects of amnoguanidine, gadolium chloride and oleanolic acid against acetmaminophen-induced hepatic and renal damage. Toxicology, 234, 124-134.
2. 2 and dependence of viability on glycolysis. Am. J. Physiol., 257, 58-64.
3. Arnold, P.E., VanPuttern, V.J., Lumlertgul, D., Burke, T.J. and Schrier, R.W. (1986): Adenine nucleotide metabolism and mitochondrial Ca2+ transport following renal ischemia. Am. J. Physiol., 250, 357-363.
4. Awadallah, R., El-Dessoukey, E.A., Doss, H., Khalifa, K. and El-Hawary, Z. (1978): Blood-reduced glutathione, serum ceruloplasmin and mineral changes in juvenile diabetes. Z. Ernäehrungswiss., 17, 79-83.
5. Bajt, M.L., Knight, T.R., Lemasters, J.J. and Jaeschke, H. (2004): Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicol. Sci., 80, 343-349.
6. Beales, D. and McLean, A. (1995): Cell injury and protection in long-term incubation of liver slices after in vivo initiation with paracetamol: cell injury after in vivo initiation with paracetamol. Toxicology, 103, 113-119.
7. Bessems, J.G.M. and Vermeulen, N.P.E. (2001): Paracetamol (Acetaminophen)-induced toxicity: Molecular and biochemical mechanisms, analogues and protective approaches. Crit. Rev. Toxicol., 31, 55-138.
8. Bjorkman, O. and Felig, P. (1982): Role of the kidney in the metabolism of fructose in 60-hour fasted humans. Diabetes, 31, 516-520.
9. Black, M. (1984): Acetaminophen hepatotoxicity. Annu. Rev. Med., 35, 577-593.
10. Bohdancecká, M, Schück, O., Chadimová, M, Sědivý, J., Glagoličová, A., Skibová, J., Kuneš, J., Dobesova, Z., Stuchílk, M., Veselá, J. and Kazdová, L. (1999): The effects of omega-3 fatty acids and vitamin E on the nephrotoxicity of cyclosporine A in hereditary hepertriglyceridemic rats. Physiol. Res., 48, 437-443.
11. Boyd, E.M. and Bereczky, G.M. (1966): Liver necrosis from paracetamol. Br. J. Pharmacol. Chemother., 26, 606-614.
12. Boyer, T.D. and Rouff, S.L. (1971): Acetaminophen-induced hepatic necrosis and renal failure. J. Am. Med. Assoc., 218, 440-441.
13. Cacini, W., Harden, E.A. and Skau, K.A. (1993): Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia. Proc. Soc. Exp. Biol. Med., 203, 348-353.
14. Chanda, S., Mangipudy, R.S., Warbritton, A., Bucci, T.J. and Mehendale, H.M. (1995): Stimulated hepatic tissue repair underlies hepatoprotection by thioacetamide against acetaminophen-induced lethality. Hepatology, 21, 477-486.
15. Cohen, A.M. (1986): Metabolic responses to dietary carbohydrates: interactions of dietary and hereditary factors. In: Metabolic effects of dietary carbohydrates. MacDonald, I., Vrana, A., editors. Prog. Biochem. Pharmacol., 21, 74-103.
16. Corcoran, G.B., Racz, W.J., Smith, C.V. and Mitchell, J.R. (1985): Effects of N-acetylcysteine on acetaminophen covalent binding and hepatic necrosis in mice. J. Pharmacol. Exp. Ther., 232, 864-872.
17. Dahlin, D.C., Miwa, G.T., Lu, A.Y.H. and Nelson, S.D. (1984): N-acethyl-p-benzoquimpme imine: A cytochrome P-450-mediated oxidation product of acetaminophen. PNAS, 81, 1327-1331.
18. 4 hepatotoxicity. Toxicology, 111, 29-42.
19. Dambach, D.M., Durham, S.K., Laskin, J.D. and Laskin, D.L. (2006): Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol. Appl. Pharmacol., 211, 157-165.
20. Dargon, P.I. and Jones, A.L. (2003): Management of paracetamol poisoning. Trends Pharmacol. Sci., 24, 154-157.
21. Davidson, D.G. and Eastham, W.N. (1966): Acute liver necrosis following overdose of paracetamol. Br. Med. J., 2, 497-499.
22. Dnyanmote, A.V., Sawant, S.P., Lock, E.A., Latendresse, J.R., Warbritton, A.A. and Mehendale, H.M. (2000): Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair. Toxicol. Appl. Pharmacol., 211, 133-147.
23. Dobyan, D.C., Levi, J., Jacobs, C., Kosek, J. and Weiner, N.M. (1980): Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J. Pharmacol. Exp. Ther., 213, 551-556.
24. Elangovan, V., Shohami, E., Gati, I. and Kohen, R. (2000): Increased hepatic lipid soluble antioxidant capacity as compared to other organs of streptozotocin-induced diabetic rats: A cyclic voltammetry study. Free Radic. Res., 32, 125-134.
25. Elliott, W.C., Houghton, D.C., Gilbert, D.N., Baines-Hunter, J. and Bennett, W.M. (1985): Experimental gentamicin nephrotoxicity: effect of streptozotocin-induced diabetes. J. Pharmacol. Exp. Ther., 233, 264-270.
26. El-Serag, H.B. and Everhart, J.E. (2002): Diabetes Increases the risk of acute hepatic failure. Gastroenterology, 122, 1822-1828.
27. El-Serag, H.B., Tran, T. and Everhart, J.E. (2004): Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology, 126, 460-468.
28. Emeigh Hart, S.G., Beierschmitt, W.P., Bartolone, J.B., Stuart Wyand, D., Khairallah, E.A. and Cohen, S.D. (1991): Evidence against deacetylation and for cytochrome P450-mediated activation in acetaminophen-induced nephrotoxicity in the CD-1 mouse. Toxicol. Appl. Pharmacol., 107, 1-15.
29. Ferreira, F.M., Palmeira, C.M., Matos, M.J., Seica, R. and Santos, M.S. (1999): Decreased susceptibility to lipid peroxidation of Goto-Kakizaki rats: Relationship to mitochondrial antioxidant capacity. Life Sci., 65, 1013-1025.
30. Gaynes, B.I. and Watkins, J.B. (1989): Carbon tetrachloride and the sorbitol pathway in the diabetic mouse. Comp. Biochem. Physiol., Part B: Biochem. Mol. Biol., 94, 213-217.
31. Grover, B., Auberger, C., Sarangarajan, R. and Cacini, W. (2002): Functional impairment of renal organic cation transport in experimental diabetes. Pharmacol. Toxicol., 90, 181-186.
32. Haagsma, B.H. and Pound, A.W. (1980): Mercuric chloride-induced tubulonecrosis in the rat kidney: the recovery phase. Br. J. Exp. Pathol., 61, 229-241.
33. Harbison, P.J., Guengerich, F.P., Rashed, M.S. and Nelson, S.D. (1988): Cytochrome P450 isozyme selectivity in the oxidation of acetaminophen. Chem. Res. Toxicol., 1, 47-52.
34. Hart, S.J., Calder, I.C. and Tange, J.D. (1982): The metabolism and toxicity of paracetamol in Sprague-Dawley and Wistar rats. Eur. J. Drug Metab. Pharmacokinet., 7, 203-222.
35. Harts, S.G., Beierschmitt, W.P., Wyand, D.S., Khairallah, E.A. and Cohen, S.D. (1994): Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicol. Appl. Pharmacol., 126, 267-275.
36. Hazelton, G.A., Hjelle, J.J. and Klaassen, C.D. (1986): Effects of butylated hydroxyanisole on acetaminophen hepatotoxicity and glucuronidation in vivo. Toxicol. Appl. Pharmacol. 83, 474-485.
37. Herzberg, G.R. and Rogerson, A.M. (1982): Interaction of the level of dietary fat and type of carbohydrate in the regulation of hepatic lipogenesis in the mouse. Can. J. Physiol. Pharmacol., 60, 912-919.
38. Hinson, J.A., Nelson, S.D. and Mitchell, J.R. (1977): Studies on the microsomal formation of arylating metabolites of acetaminophen and phenacetin. Mol. Pharmacol., 13, 625-633.
39. Hinson, J.A. (1980): Biochemical toxicology of acetaminophen. Rev. Biochem. Toxicol., 2, 103-130.
40. Hjelle, J.J. (1986): Hepatic UDP-glucuronic acid regulation during acetaminophen biotransformation in rats. J. Pharmacol. Exp. Ther., 237, 750-756.
41. Hollenberg, N.K. (2004): Treatment of the patient with diabetes mellitus and risk of nephropathy: what do we know, and what do we need to learn? Arch. Intern. Med., 164, 125-130.
42. Hoivik, D.J., Manautou, J.E., Tveit, A., Hart, S.G., Khairallah, E.A. and Cohen, S.D. (1995): Gender-related differences in susceptibility to acetaminophen-induced protein arylation and nephrotoxicity in the CD-1 mouse. Toxicol. Appl. Pharmacol., 130, 257-271.
43. Hojo, M., Hanioka, K., Miyata, M. and Yamazoe, Y. (2000): Hepatotoxicity of acetaminophen and N-acetyl-p-benzoquinone imine and enhancement by fructose. Xenobiotica, 30, 933-941.
44. Hoshiyama, M., Li, B., Yao, J., Harada, T., Morioka, T. and Oite, T. (2003): Effect of high glucose on nitric oxide production and endothelial nitric oxide synthase protein expression in human glomerular endothelial cells. Nephron Exp. Nephrol., 95, 62-68.
45. Howell, S.R. and Klaasen, C. (1991): Circadian variation of hepatic UDP-glucuronic acid and the glucuronidation of xenobiotics in mice. Toxicol. Lett., 57, 73-79.
46. Huerta, C., Zhao, S.Z. and Garcia Rodriguez, L.A. (2002): Risk of acute liver injury in patients with diabetes. Pharmacotherapy, 22, 1091-1096.
47. Hunt, J.V. and Wolff. S.P. (1991): Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Radical Res., 12, 115-123.
48. Illing, E.K.B, Gray, C.H. and Lawrence, R.D. (1951): Blood glutathione and non-glucose reducing substances in diabetes. Biochem. J., 48, 637-640.
49. Ishida, K., Hanada, T., Sakai, T. and Doi, K. (1995): Effects of fructose-induced hypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats. Exp. Toxic. Pathol., 47, 509-516.
50. Ishida, K., Ikegami, H. and Doi, K. (1997a): Enhanced nephrotoxicity of acetaminophen in fructose-induced hypertriglyceridemic rats: Contribution of oxidation and deacetylation of acetaminophen to an enhancement of nephrotoxicity. Exp. Toxic. Pathol., 49, 313-319.
51. Ishida, K., Okuda, R., Ikegami, H., Ito, K., Nagamatsu, N., Fukuda, Y., Nukui, E. and Doi, K. (1998): Acetaminophen-induced hepatorenal toxicity in high fructose diet-fed rats is sex-dependent. J. Toxicol. Pathol., 11, 101-107.
52. Ishida, K., Sakazume, M., Hirai, N., Ikegami, H., Sakai, T. and Doi, K.(1997b): Effects of fructose-inducedhypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats. II. Role of enhancement of fructose metabolism and overproduction of triglyceride in the liver and kidney on hepatorenal toxicity of acetaminophen. Exp. Toxic. Pathol., 49, 39-46.
53. Ishida, K., Sakazume, M., Ikegami and Doi, K. (1997c): Enhanced nephrotoxicity of acetaminophen in fructose-induced hypertriglyceridemic rats: Effect of partial hepatectomy. Exp. Toxic. Pathol., 49, 321-327.
54. Ishida, K., Sakazume, M., Watanabe, M., Hirai, N., Ikegami, H., Sakai, T. and Doi, K. (1997d): Effects of fructose-induced hypertriglyceridemia on hepatorenal toxicity of acetaminophen in rats: Role of pharmacokinetics and metabolism of acetaminophen. Exp. Toxic. Pathol., 49, 207-215.
55. Iwata, K., Inayama, T. and Kato, T. (1990): Effects of Spirulia platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr. Sci. Vitaminol., 36, 165-171.
56. Jawa, A., Kcomt, J. and Fonseca, V.A. (2004): Diabetic nephropathy and retinopathy. Med. Clin. North Am., 88, 1001-1036.
57. Jeffery, E.H., Arndt, K. and Haschek, W.M. (1991): The role of cytochromeP450IIE1 in bioactivation of acetaminophen in diabetic and acetone-treated mice. Adv. Exp. Med. Biol., 283, 249-251.
58. Jollow, D.J., Thorgeirsson, S.S., Potter, W.Z., Hashimoto, M. and Mitchell, J.R. (1974): Acetaminophen-induced hepatic necrosis VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology, 12, 251-271.
59. Jones, A.L., Jarvie, D.R., Simpson, D., Hayes, P.C. and Prescott, L.F. (2003): Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease. Alimentary Pharmacol Ther., 11, 787-791.
60. Jones, D.P. and Mason, H.S. (1978): Gradients of O2 concentration in hepatocytes. J. Biol. Chem., 253, 4874-4880.
61. Kazumi, T., Vranic, M. and Steiner, G. (1986): Triglyceride kinetics: effects of dietary glucose, sucrose,or fructose alone or with hyperinsulinemia. Am. J. Physiol. Endocrinol. Metab., 250, 325-330.
62. Kedziora-Kornatowska, K., Szram, S., Kornatowski, T., Szadujkis-Szadurski, L., Kedziora, J. and Bartosz, G. (2003): Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Exp. Nephrol., 95, 134-143.
63. Kluwe, W.M. and Hook, J.B. (1981): Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsomal enzyme inhibitor piperonyl butoxide. Toxicol. Appl. Pharmacol., 59, 457-466.
64. Korrapati, M.C., Lock, E.A. and Mehendale, H. (2005): Molecular mechanisms of enhanced renal cell division in protection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death. Am. J. Physiol. Renal. Physiol., 289, 175-185.
65. Kulmatycki, K.M., Abouchehade, K., Sattari, A. and Jamali, F. (2001): Drug-disease interactions: reduced β-adrenergic and potassium channel antagonist activities of sotalol in the presence of acute and chronic inflammatory conditions in the rat. Br. J. Pharmacol., 133, 286-294.
66. Kuo, C-H. and Hook, J.B. (1980): Postnatal development of renal and hepatic drug-metabolizing enzymes in male and female Fischer 344 rats. Life Sci., 27, 2433-2438.
67. Lal, S.K. and Kumar, S. (1967): Effect of ketosis on the blood glutathione levels in the diabetic. Indian. J. Med. Res., 55, 495-496.
68. Laurent, G., Toubeau, G., Heuson-Stiennon, J.A., Tulkens, P., Maldague, P. and Vaamonde, C.A. (1988): Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization. Crit. Rev. Toxicol., 19, 147-183.
69. Limaye, P.B., Apte, U.M., Shanker, K., Bucci, T.J., Wrbritton, A. and Mehendale, H.M. (2003): Calpain released from dying hepatocytes mediates progression of acute liver injury induced by model hepatotoxicants. Toxicol. Appl. Pharmacol., 191, 211-226.
70. Limaye, P.B., Bhave, V.S., Palkar, P.S., Apte, U.M., Latendresse, J.R., Yu, S., Kashireddy, P., Reddy, J.K. and Mehendale, H.M. (2005): Calpastatin over-expression protects against toxicant-induced progression of injury associated with acute liver failure in mice. Toxicologist, 84, 77.
71. Lindall, A.W., Grande, F. and Schultz, A. (1971): The effect of dietary fats on the serum lipoproteins of normal dogs. Proc. Soc. Exp. Biol. Med., 136, 1032-1037.
72. Linscheer, W.G., Raheja, K.L., Cho, C. and Smith, N.J. (1980): Mechanism of the protective effect of propylthiouracil against acetaminophen (Tylenol) toxicity in the rat. Gastroenterology, 78, 100-107.
73. Liu, Z.X. and Kaplowitz, N. (2006): Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol., 2, 493-503.
74. Lucas, D., Farez, C., Bardou, L.G., Vaisse, J., Attali, J.R. and Valensi, P. (1998): Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam. Clin. Pharmacol., 12, 553-558.
75. Lucas, A.M., Henning, G. Dominick, P.K., Whiteley, H.E., Roberts, J.C. and Cohen, S.D. (2000): Ribose cysteine protects against acetaminophen-induced hepatic and renal toxicity. Toxicol. Pathol., 28, 697-704.
76. MacDonald, T.F., Hunter, E.G. and MacLeod, D.P. (1971): Adenos-inetriphosphate partition in cardiac muscle with respect to trans-membrane electrical activity. Pflugers Arch., 322, 95-108.
77. Mazur, A., Gueux, E., Felgines, C., Bayle, D., Nassir, F., Dominge, R. and Remesy, C. (1992): Effects of dietary fermentable fiber on fatty acid synthesis and triglyceride secretion in rats fed fructose-based diet: Studies with sugar-beet fiber. Proc. Soc. Exp. Biol. Med., 199, 345-350.
78. McMurty, R.J., Snodgrass, W.R. and Mitchell, J.R. (1978): Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol. Appl. Pharmacol., 46, 87-100.
79. Mehendale, H.M. (1995): Injury and repair as opposing forces in risk assessment. Toxicol. Lett., 82-83, 891-899.
80. Mitchell, J.R., Jollow, D.J., Potter, W.Z., Gillete, J.R. and Brodie, B.B. (1973): Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther., 187, 211-217.
81. Meyers, L.L., Beierschmitt, W.P., Khairallah, E.A. and Cohen, S.D. (1988): Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. Toxicol. Appl. Pharmacol., 93, 378-387.
82. Mour, G., Feinfeld, D.A., Caraccio, T. and McGuigan, M. (2005):Acute renal dysfunction in acetaminophen poisoning. Renal Fail., 27, 381-383.
83. Mourelle, M., Beales, D. and McLean, A.E.M. (1991): Prevention of paracetamol-induced liver injury by fructose. Biochem. Pharmacol., 41, 1831-1837.
84. Mugford, C.A. and Tarloff, J.B. (1995): Contribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague-Dawley rats. Drug Metab. Dispos., 23, 290-294.
85. Mukherjee, B., Mukherjee, J.R. and Chatterjee, M. (1994): Lip-id peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol. Cell. Biol., 72, 109-114.
86. Newton, J.F., Kuo, C.H., DeShone, G.M., Hoefle, D., Bernstein,J. and Hook, J.B. (1985): The role of p-aminophenol in acetaminophen-induced nephrotoxicity: effect of bis(p-nitrophenyl) phosphate on acetaminophen and p-aminophenol nephrotoxicity and metabolism in Fischer 344 rats. Toxicol. Appl. Pharmacol., 81, 416-430.
87. Nikkilä, E.A. and Ojala, K. (1964): Hyperglyceridemia induced by glycerol feeding. Life Sci., 3, 1021-1023.
88. Novak, R.F. and Woodcroft, K.J. (2000): The alcohol-inducible form of cytochrome P450 (CYP2E1): role in toxicology and regulation of expression. Arch. Pharmacol Res., 23, 267-282.
89. Pohl, L.R., Bhooshan, B., Whitaker, N.F. and Krishna, G. (1977): Phosgen: A metabolite of chloroform. Biochem. Biophys. Res. Commun., 79, 684-691.
90. Potter, W.Z., Thorgeirsson, S.S., Jollow, D.J. and Mitchell, J.R. (1974): Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology, 12, 128-143.
91. Prescott, L.F., Wright, N., Roscoe, P. and Brown, S.S. (1971): Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet, 297, 519-522.
92. Price, V.F. and Jollow, D.J. (1981): Resistance of diabetic rats to acetaminophen hepatotoxicity: Role of co-substrate. Fed. Proc., 40, 724.
93. Price, V.F. and Jollow, D.J. (1982): Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J. Pharmacol. Exp. Ther., 220, 504-513.
94. Price, V.F. and Jollow, D.J. (1989): Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem. Pharmacol., 38, 289-297.
95. Proudfoot, A.T. and Wright, N. (1970): Acute paracetamol poisoning. Br. Med. J., 3, 557-558.
96. Qiu, Y., Benet, L.Z. and Burlingame, A.L. (1998): Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry. J. Biol. Chem., 273, 17940-17953.
97. Raheja, K.L., Linscheer, W.G. and Cho, C. (1983): Hepatotoxicity and metabolism of acetaminophen in male and female rats. J. Toxicol. Environ. Health, 12, 143-158.
98. Raheja, K.L., Linscheer, W.G., Cho, C. and Mahany, D. (1982): Protective effect of propylthiouracil independent of its hypothyroid effect on acetaminophen toxicity in the rat. J. Pharmacol. Exp. Ther., 220, 427-432.
99. Ramaswamy, M., Peteherych, K.D., Kennedy, A.L. and Wasan, K.M. (2001): Amphotericin B lipid complex or amphotericin B multiple-dose administration to rabbits with elevated plasma cholesterol levels: pharmacokinetics in plasma and blood, plasma lipoprotein levels, distribution in tissues, and renal toxicities. Animicrob. Agents Chemother., 45, 1184-1191.
100. Rao, P.S., Dalu, A., Kulkarni, S.G. and Mehendale, H.M. (1996): Stimulated tissue repair prevents lethality in isopropanol-induced potentiation of carbon tetrachloride hepatotoxicity. Toxicol. Appl. Pharmacol., 140, 235-244.
101. Ruepp, S.U., Tonge, R.P., Shaw, J., Wallis, N. and Pognan, F. (2002): Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci., 65, 135-150.
102. Saad, S.Y. and Naijar, T.A., (2005): Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats. Arch. Toxicol., 79, 493-499.
103. Sakuma, T., Honma, R., Maguchi, S., Tamaki, H. and Nemoto, N. (2001): Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica, 31, 223-237.
104. Santos, M.S., Santos, D.L., Palmeira, C.M., Seica, R., Moreno, A.J. and Oliveira, C.R. (2001): Brain and liver mitochondria isolated from diabetic Goto-Kakizaki rats show different susceptibility to induced oxidative stress. Diabetes Metab. Res. Rev., 17, 223-230.
105. Sawant, S.P., Dnyanmote, A.V., Shankar, K., Limaye, P.B., Latendresse, J.R. and Mehendale, H.M. (2004): Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. J. Pharmacol. Exp. Ther., 308, 694-704.
106. Sawant, S.P., Dnyanmote, A.V., Mitra, M.S., Chilakapati, J.,Warbritton, A., Latendresse, J.R. and Mehendale, H.M. (2006): Protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss-Webster mice. J. Pharmacol. Exp. Ther., 316, 507-519.
107. Shankar, K., Vaidya, V.S., Apte, U.M., Manautou, J., Ronis, M.J., Bucci, T.J. and Mehendale, H.M. (2003a): Type 1 diabetic mice are protected from acetaminophen hepatotoxicity. Toxicol. Sci., 73, 220-234.
108. Shankar, K., Vaidya, V.S., Manautou, J.E., Ronis, M.J.J., Corton, J.C., Bucci, T.J. and Mehendale, H.M. (2002): Activation of PPAR-alpha is pivotal in diabetes-induced resistance against acetaminophen hepatotoxicity: Understanding mechanisms via microarray analyses. Hepatology, 36, 332.
109. Shankar, K., Vaidya, V.S., Wang, T., Bucci, T.J. and Mehendale, H.M. (2003b): Streptozotocin-induced diabetic mice are resistant to lethal effects of thioacetamide hepatotoxicity. Toxicol. Appl. Pharmacol., 188, 122-134.
110. Shapiro, J.I., Chan, L., Cheung, C., Itabashi, A., Rossi, N.F. and Schrier, R.W. (1987): Effects of adenosine triphosphate depletion in the isolated perfused rat kidney. Miner Electrolyte Metab., 13, 415-421.
111. Shapiro, J.I., Mills, S., Cheung, C., Shanley, P.F., Schrier, R.W. and Chan, L. (1989): Effect of adenosine triphosphate depletion in vivo on renal function in the rat with and without ischemia. Miner Electrolyte Metab., 15, 276-282.
112. Sharma, K., Han, D.C., Mogyorosi, A. and Ziyadeh, F.H. (1999): Structural and functional consequences of streptozotocin-induced diabetes on the kidney. In: McNail JH editor. Experimental Models of Diabetes., pp 3-55, CRC Press, Boca Raton, FL.
113. Shimizu, H., Uetsuka, K., Nakayama, H. and Doi, K. (2001): Carbon tetrachloride-induced acute liver injury in Mini and Wistar rats. Exp. Toxicol. Pathol., 53, 11-18.
114. Sols, A., Salas, M. and Vinuela, E. (1964): Induced biosynthesis of liver glucokinase. Adv. Enzym. Regul., 2, 177-188.
115. Soni, M.G. and Mehendale, H.M. (1998): Role of tissue repair in toxicologic interactions among hepatotoxic organics. Environ. Health Perspect., 106, 1307-1317.
116. Spence, J.T. and Pitot, H.C. (1982): Induction of lipogenic enzymes in primary cultures of rat hepatocytes. Relationship between lipogenesis and carbohydrate metabolism. Eur. J. Biochem., 128, 15-20.
117. Steiner, G., Haynes, F.J., Yoshino, G. and Vranic, M. (1984): Hyper-insulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics. Am. J. Physiol., 246, 187-192.
118. Stern, S.T., Bruno, M.K., Henning, G.E., Horton, R.A., Roberts, J.C. and Cohen, S.D. (2005a): Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice. I. Enhancement of acetaminophen nephrotoxicity by acetami-nophen-cysteine. Toxicol. Appl. Pharmacol., 202, 151-159.
119. Stern, S.T., Bruno, M.K., Horton, R.A., Hill, D.W., Roberts, J.C. and Cohen, S.D. (2005b): Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity. II. Possible involvement of the gamma-glutamyl cycle. Toxicol. Appl. Pharmacol., 202, 160-171.
120. Sukalski, K.A., Pinto, K.A. and Berntson, J.L. (1993): Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase in alpha-tocopherol. Free Radic. Biol. Med., 14, 57-65.
121. Sumioka, I., Matsura, T., Kai, M. and Yamada, K. (2004): Potential roles of hepatic heat shock protein 25 and 70i in protection of mice against acetaminophen-induced liver injury. Life Sci., 74, 2551-2661.
122. Sweeny, D., Eacho, P.L. and Weiner, M. (1981): Carbohydrate effects on conjugation of p-nitrophenol in hepatocytes of normal and diabetic rats. Fed. Proc., 40, 734.
123. Tarloff, J.B. and Goldstein, R.S. (1994): Biochemical mechanisms of renal toxicity. In: Hodgson E, Levi PE, editors. Introduction to Biochemical Toxicology. 2nd edition. Appleton & Lange, pp 519-546.
124. Tarloff, J.B., Khairallah, E.A., Cohen, S.D. and Goldstein, R.S. (1996): Sex- and age-dependent acetaminophen hepato- and nephrotoxicity in Sprague-Dawley rats: Role of tissue accumulation, nonprotein sulfhydryl depletion, and covalent binding. Toxicol. Sci., 30, 13-22.
125. Tolson, J.K., Dix, D.J., Voellmy, R.W. and Roberts, S.M. (2006): Increased hepatotoxicity of acetaminophen in Hsp70i knockout mice. Toxicol. Appl. Pharmacol., 210, 157-162.
126. Vaamonde, C.A., Bier, R.T., Gouvea, W., Alpert, H., Kelley, J. and Pardo, V. (1984): Effect of duration of diabetes on the production observed in the diabetic rat against gentamicin-induced acute renal failure. Miner. Electrolyte Metab., 10, 209-216.
127. Valentovic, M.A., Scott, L.A., Madan, E. and Yokel, R.A. (1991): Renal accumulation and urinary excretion of cisplatin in diabetic rats. Toxicology, 70, 151-162.
128. Valentovic, M.A., Alejandro, N., Betts Carpenter, A., Brown, P.I. and Ramos, K. (2006): Streptozotocin (STZ) diabetes enhances benzo(alpha)pyrene induced renal injury in Sprague Dawley rats. Toxicol. Lett., 164, 214-220.
129. Van Groeningen, C., Van der Vijgh, W.J.F., Baar, J.J., Stieltjes, H., Huibregtse, K. and Pinedo, H.M. (2000): Altered pharmacokinetics and metabolism of CPT-11 in liver dysfunction: A need for guideline. Clin. Cancer Res., 6, 1342-1346.
130. Vendemiale, G., Grattagliano, I., Altomare, E., Turturro, N. and Guerrieri, F. (1996): Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem. Pharmacol., 52, 1147-1154.
131. Wang, T., Shankar, K., Ronis, M.J. and Mehendale, H.M. (2000): Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1. J. Pharmacol. Exp. Ther., 294, 473-479.
132. Wang, Z., Hall, S.D., Maya, J.F., Li, L., Asghar, A. and Gorski, J.C. (2003): Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br. J. Clin. Pharmacol., 55, 77-85.
133. Watkins, J.B., Klaunig, J.E., Smith, H.M., Cornwel, P. and Sanders, R.A. (1998): Streptozotocin-induced diabetes increases gamma-glutamyltranspeptidase activity but not expression in rat liver. J. Biochem. Mol. Toxicol., 12, 219-225.
134. Weiss, J.N. and Lamp, S.T. (1987): Glycolysis preferentially inhibits ATP sensitive K+ channels in isolated guinea pig cardiac myocytes. Science, 238, 67-69.
135. Yang, D.W., Jia, R., Yang, D.P., Ding, G.H. and Huang, C.X. (2004): Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin. Med. J. (Engl.), 117, 542-546.
136. Yoshino, G., Matsushita, M., Iwai, M., Morita, M., Matsuba, K., Nagata, K., Maeda, E., Furukawa, S., Hirano, T. and Kazumi, T. (1992): Effect of mild diabetes and dietary fructose on very-low-density lipoprotein triglyceride turnover in rats. Metabolism, 41, 236-240.
137. Zaher, H., Buters, J.T.M., Ward, J.M., Bruno, M.K., Lucas, A.M., Stern, S.T., Gonzalez, F.J. and Cohen, S.D. (1998): Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol., 152, 193-199.